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The 22nd Annual Meeting of the European Tissue Repair Society, Athens, Greece, October 4 to 5, 2012 informed
about pathophysiological mechanisms in tissue repair and on the development of clinical treatments of chronic
wounds, fibrosis, and cancer, considering recent advances in molecular biology and biotechnology.
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Pathological healing is a leading cause of morbidity and
mortality despite significant advance of wound care in
the 20th century. Severely injured organs cannot always
be regenerated by the routine repair mechanisms of the
body, thus necessitating the development of novel ther-
apies. The 22nd Annual Meeting of the European Tissue
Repair Society (ETRS) was organized by Dimitris Kletsas
and colleagues in Athens, Greece, from October 4 to 5,
2012 with almost 200 clinical and fundamental scientist
attendees (Figure 1).
The 15 main sessions of the ETRS Annual Meeting
[http://www.etrs.org] and the 60 posters on display covered
the role of stem cells and cell therapies, growth factors
(GF), angiogenesis, mechanical factors, biomaterials and
nanotechnology, cell senescence, inflammation, and cell-
extracellular matrix (ECM) interactions in tissue repair and
regeneration (abstracts published in Wound Repair and
Regeneration 2012, Volume 20(5)). Special sessions dis-
cussed infections, burns and chronic wounds, systems biol-
ogy approaches to understand tissue repair, and the
similarity between wound repair and cancer development.
The ETRS meeting also hosted workshops given by the in-
dustry partners Integra and Bruker, and a guest session
from the European Wound Management Association
(EWMA). The proteomics workshop by Bruker was or-
ganized in collaboration with the ETRS Junior Committee,
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reproduction in any medium, provided the orscientists. Traditionally, ETRS meetings provide a platform
for young investigators and more than 30 talks were
selected from early stage researchers, of which nine
competed in the Young Investigator’s Award session. This
year’s winner was Eirini Apostolou (Biomedical Research
Foundation Academy of Athens, Greece), who will be
invited to present at the 2013 Annual Meeting of the ETRS
partner organization, the Wound Healing Society (WHS),
in Denver, Colorado. The next annual meeting of the ETRS
will be organized from October 23–25 in Reims, in the
beautiful Champagne region of France. Hands-on research
on antioxidants is to be expected.The clinical impacts of poor and excessive healing
The Ying of wound healing - chronic wounds
Insufficient healing causes a high level of mortality and
morbidity and is an important cost factor for the global
health care system. Chronic wounds are present in 2% of
the patients in Western countries and 1% worldwide.
Chronic wounds particular affect diabetics, physically
disabled, elderly and patients with vascular diseases, as
was shown in a cross-sectional study performed in India.
Finding effective treatments to restore normal healing in
chronic wounds and measuring the outcomes are major
challenges for clinical therapies, which was discussed in
several talks. Risk factors include smoking, whereas
smoking cessation and nicotine replacement therapy was
shown to improve healing. Other treatments include ne-
gative pressure wound therapy (NPWT), and platelet-
rich fibrin for general regeneration support.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Official poster announcement of the 22nd Annual
Meeting of the European Tissue Repair Society, Athens, Greece,
October 4 to 5, 2012.
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infection. Mouse models demonstrate a systemic negative
effect of local sepsis on the inflammatory response. Differ-
ent concepts were presented to target/prevent bacterial in-
fection and biofilm formation, including treatment with
local polyhexamethylene biguanidine antiseptics. It was
postulated that in some cases, adequately used local anti-
septics could prevent the need for systemic antibiotics.
Novel concepts involve the use of dextrin-colistin poly-
mers to interfere with biofilm growth and stability and to
deliver GFs to the wound bed. Other innovative systems
that may improve chronic wound healing include a non-
viral piggyback transposon system for gene delivery and
nanostructured polymer containers constructed of mag-
netic nanoparticles to deliver GFs. Such GFs may include
Epidermal GF (EGF) to support re-epithelialization or
tumor necrosis factor α to control ECM reorganization by
matrix metalloproteinases.
Chronic wound healing is often associated with ische-
mia and with low levels of tissue O2 (hypoxia); hypoxia
is accepted to be one of the main risk factors for chronic
wounds. One session focused on the molecular mecha-
nisms of angiogenesis as targets to support tissueoxygenation. Several biomolecules were addressed, in-
cluding anti-angiogenic molecules such as advanced
glycation end products and pro-angiogenic molecules
such as vascular endothelial GF (VEGF), nucleolin, talin
and epoxyeicosatrienoic acids. The role of Interleukin-
10 was discussed in a talk given by Swati Balaji (Cincinnati
Children’s Hospital Medical Center, Cincinnati, OH), the
Young Investigator Award winner of the Wound Healing
Society’s 2012 Annual Meeting.The Yang of wound healing - fibrosis and contractures
Excessive healing involves the excessive and persistent
accumulation of ECM, inflammatory cells and repara-
tive cells, which are common in organ fibrosis and skin
hypertrophic scarring, such as after large area burns.
According to the American Burn Association, approxi-
mately 45% of patients with burn wounds died in the
period 2001 to 2010 when more than 50% of the skin
surface was destroyed. Hypertrophic scars arise from
imperfect dermis regeneration and can immobilize
digits and limbs; furthermore, the poor esthetics of the
scar enormously impact on the patient’s quality of life.
A workshop organized by Integra presented ECM res-
toration strategies to support the formation of a neo-
dermis in burns and in post-traumatic and post-surgical
wounds.
A number of talks discussed the molecular mecha-
nisms of fibrosis development in other organs and
conditions. Deciphering common traits in the patho-
physiological processes will be beneficial to develop
novel anti-fibrosis strategies. Such approaches include
systems biology (for example, gene array meta-analysis
of human keloid scars and control tissue, data analysis
from a longitudinal human platform to model pro-
cesses and pathways in variety of pathologies including
wound healing). A workshop organized by Bruker
informed researchers of the use, principles and instru-
mentation of proteomic analysis for wound healing
research. To identify processes involved in airway scar-
ring, ex vivo organ cultures of early non-scarring and
late developmental stage scarring fetal rat airways were
presented as another model for detecting patterns of
pro-fibrotic gene clusters. In-depth analysis of selected
pathways and molecules was presented for the pro-
fibrotic/wound healing supporting roles of TAK1, a
downstream effector of non-Smad transforming GF β1
(TGFβ1) signaling, the β2 adrenoceptor, Trefoil family
factor 2 (TFF2) and CCN2 (Connective tissue growth
factor, CTGF). The pro-fibrotic cytokine TGFβ was
shown to play a major role in normal adult lung repair,
whereas Bone morphogenetic protein (BMP) is preva-
lent during development. The data suggested that dur-
ing lung injury, BMP is expressed by cells with stem
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tiated cells.Inflammation plays a role in chronic wound healing and
fibrosis
Inflammatory cells can be both beneficial and detri-
mental to the outcome of tissue and organ repair. The
inflammatory response and the hepatic regeneration
potential were compared in animal models of open and
laparoscopic left partial hepatectomy. The open surgi-
cal procedure resulted in a higher systemic inflamma-
tory response and improved liver regeneration. Viral
overexpression of Activin A in mouse lungs leads to
chronic inflammation and generates a phenotype that
resembles human acute respiratory stress syndrome
(ARDS). In another study, histatins were presented to
supporting re-epithelialization and wound healing, pos-
sibly by modulating the inflammatory response. In
chronic wounds, macrophage polarization was presen-
ted as a critical event in wound healing. Whereas the
pro-inflammatory macrophage M1 type prevails in
chronic wounds, a switch to the M2 macrophage ap-
pears to improve healing. This switch can be induced
by delivered mesenchymal progenitor cells (MSCs).The use of multipotent mesenchymal progenitor
cells (MSCs) for improved tissue repair
A main focus of the meeting was the use of MSCs to
improve tissue repair and regeneration when the body’s
repair mechanisms fail. MSCs contribute directly to
tissue repair by exerting remodeling activity and by add-
itionally exerting immunosuppressive, trophic, antisep-
tic, chemotactic, and differentiating effects on other cell
populations in the wound environment. Furthermore,
MSCs have been proposed as drug and gene-delivery
vehicles and a number of methods have been presented
to prepare MSCs for implantation purposes into differ-
ent organs. In addition to the best characterized bone-
marrow-derived MSCs, MSCs derived from adipose
tissue or oral gingiva were introduced as attractive new
cell sources to repair scarring burn skin wounds and
chronic wounds, as well as to support the regeneration
of diseased liver. For tissue regeneration of the soft pal-
ate of the cleft lip, MSCs derived from limb and head
muscles were compared with respect to their differenti-
ation potential. Moreover, bulge cells derived from hair
follicles have been shown to provide a potential source
of cells for wound repair. In addition to presenting the
scientific and clinical potential of MSCs, practical as-
pects were discussed at the meeting, such as tissue and
cell banking and drawbacks of the changing EU legisla-
tion concerning the use of stem cells.The microenvironment affects the regenerative
potential of reparative cells
The meeting sensitized all attendees to the fact that the
chemical and mechanical conditions present in different
injured tissues are important determinants of the cellu-
lar repair process and have to be considered for the devel-
opment of treatment strategies for tissue regeneration. In
cartilage, steep gradients of oxygen, glucose, and pH be-
tween the surface and the interior are generated due to the
avascular nature of the tissue. Different dental scaffolds for
tooth repair were shown to have different suitability for use
with different oral-derived MSCs. In skin regeneration, it is
important to suppress potential fibrotic characteristics of
MSCs induced by expansion cell culture. Similarly, culture-
induced senescence of MSCs was flagged as being detri-
mental for wound healing and tissue regeneration because
of the pro-inflammatory state of senescent MSCs.
The mechanical conditions present in tissue under re-
pair, such as strain and ECM stiffness, were highlighted
as particularly important factors for the repair success.
Extracellular proteins including Periostin and Cartilage
oligomeric matrix protein (COMP) provide cell informa-
tion on the physical state of the ECM. This mechanical
information is perceived through integrin containing
cell-ECM adhesions. The specific roles of different inte-
grins were discussed for epithelial and fibroblast cell
differentiation and different knock-out models were
phenotyped. Cell-ECM adhesions and transmembrane
integrins are intracellularly linked to the actin/myosin
cytoskeleton. It was shown that cell shape, dictated by
the ECM configuration, regulates internal stress and the
polymerization degree of actin. In turn, the content
of globular actin controls the translocation of the
myocardin-related transcription factor MRTF from the
cytosol to the nucleus and thus, stress-dependent gene
expression. Another mechanotransduction pathway in-
volves the activation of the JAK/STAT pathway, and a
new link between the mechanical activation of TGFβ1
and ECM stiffness was revealed.
Modulation of mechanical stress is clinically exploited to
improve chronic wound healing. With more than 20 differ-
ent NPWT systems on the market, the search for their
mechanisms of action has revealed mechanical stress as a
critical component of NPWT therapy success. Negative
pressure induces tissue macro- and micro-deformations
and fluid shear forces that impact the activity of fibroblasts,
blood vessels and lymphatics, in combination with the ma-
terial properties of the NPWT foam.
The similarities between tissue repair and cancer
Cancer development is similarly driven by the mechanical
properties present in the stroma. The similarities in
growth factor signaling, neo-vascularization and tissue
remodeling between cancer and wound healing was
Hinz et al. Fibrogenesis & Tissue Repair 2013, 6:3 Page 4 of 4
http://www.fibrogenesis.com/content/6/1/3addressed in the Charles Lapière memorial keynote lecture
given by Dr. Sabine Werner (Eidgenössische Technische
Hochschule Zürich, Switzerland). Dr. Werner focused on
three recently studied proteins in cancer and wound
healing: 1) perioxyredoxin 6 seems to protect skin from
development of benign tumors by controlling lipid and
protein oxidation but conversely promotes transition of
benign to malignant tumors by protecting cancer cells from
oxidative stress; 2) the transcription factor Nrf3 is down-
regulated during epidermal healing in keratinocytes and
seems to be a negative regulator of normal healing; and 3)
the transcription factor Nrf2 is highly expressed in
suprabasal keratinocytes in the skin epidermis and regulates
the antioxidant defense system. Constitutively active Nrf2
expressed under a keratinocyte-specific promoter protects
from tumorigenesis but leads to ichtyosis and hyperkera-
tosis. The potential of pharmacological activators of Nrf2 in
affecting tumorigenesis is currently under investigation.
A number of other talks underlined that various ECM
molecules which are important during wound healing influ-
ence cancer malignancy; in turn, cancer cells modulate the
expression of ECM molecules in the stroma. For instance,
paracrine factors released by breast cancers cells stimulate
endothelial cells to express hyaluronic acid, its receptor
CD44 and the adhesion molecules VCAM and ICAM. In
turn, MT1-matrix metalloproteinase expression and endo-
thelial cell migration are reduced. Collectively, it became
evident at the meeting that knowledge and therapies
generated in the field of cancer research are of tremendous
use for chronic and excessive wound healing and vice versa.
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